PEComa
PEComa | |
Histopathologic image of renal angiomyolipoma. Nephrectomy specimen. H&E stain. | |
MeSH | D054973 |
WikiDoc Resources for PEComa |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on PEComa at Clinical Trials.gov Clinical Trials on PEComa at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on PEComa
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating PEComa Risk calculators and risk factors for PEComa
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
In oncology, PEComa, also PEC tumour and perivascular epithelioid cell tumour, is a type of mesenchymal tumour consisting of perivascular epithelioid cells (PECs).[1]
Pathophysiology
Microscopic Pathology
PECs consist of perivascular epithelioid cells with a clear/granular cytoplasm and central round nucleus without prominent nucleoli.
Genetics
The precursor cell of PEComas is currently unknown.[1] Genetically, PECs are linked to the tuberous sclerosis genes TSC1 and TSC2.
Differentiating PEComa from other Diseases
PECs bear significant histologic and immunohistochemical similarity to:
- Angiomyolipoma,
- Clear-cell sugar tumour (CCST),
- Lymphangioleiomyomatosis, and,
- Clear-cell myomelanocytic tumour of ligamentum teres/falciform ligament.
Thus, it has been advocated that the above could be classified PEComas.[1]
Diagnosis
Immunohistochemical markers
PECs typically stain for melanocytic markers (HMB-45, Melan A (Mart 1), Mitf) and myogenic markers (actin).
References